N-Nitroso Nintedanib

N-nitrosonintedanib or methyl (Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-1-nitroso-2-oxoindoline-6-carboxylate, is a triple angiokinase inhibitor , is a small molecule, competitive that used for the treatment of idiopathic pulmonary fibrosis, interstitial lung disease. it acts to inhibit platelet-derived growth factor, and fibroblast growth factor receptors.

Additional information on N-nitrosonintedanib

Catalogue No.

VE009400

CAS No.

N/A

Molecular Formula

C31H32N6O5

Molecular Weight

568.62 g/mol

Parent drug

Nintedanib

IUPAC Name

methyl (Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-1-nitroso-2-oxoindoline-6-carboxylate

Synonyms

N/A

References

Rivera-Ortega, Pilar, et al. “Nintedanib in the Management of Idiopathic Pulmonary Fibrosis: Clinical Trial Evidence and Real-World Experience.” Therapeutic Advances in Respiratory Disease, vol. 12, Jan. 2018, p. 175346661880061, https://doi.org/10.1177/1753466618800618. ‌

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

N-Nitroso Nintedanib

N-Nitroso Nintedanib
Catalogue No.

VE009400

CAS No.

N/A

Molecular Formula

C31H32N6O5

Molecular Weight

568.62 g/mol

Parent drug

Nintedanib

IUPAC Name

methyl (Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-1-nitroso-2-oxoindoline-6-carboxylate

Synonyms

N/A

References

Rivera-Ortega, Pilar, et al. “Nintedanib in the Management of Idiopathic Pulmonary Fibrosis: Clinical Trial Evidence and Real-World Experience.” Therapeutic Advances in Respiratory Disease, vol. 12, Jan. 2018, p. 175346661880061, https://doi.org/10.1177/1753466618800618. ‌

Status

In-stock

ListName

N-nitrosonintedanib

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden